Marilen Benner

UTERINE LYMPHOCYTES GAIN EXPERIENCE DURING PREGNANCY 45 2 Supplementary Table S2. Mean % ± SD is provided for lymphocyte populations in the three study groups as used in the figures. Peripheral blood Menstrual blood Decidua Lymphocytes 79.1±6.9 62.5±12.1 65.2±9.8 T cells (CD3 + CD56 - ) 80.0±7.3 43.9±15.1 67.1±10.6 CD45RA + 50.9±7.7 53.4±8.8 17.2±7.4 CD45RO + 31.2±7.1 28.9±8.0 66.4±11.7 CD4 + T cells 64.6±9.7 64.7±7.4 50.3±7.0 Naive (CD45RA + CCR7 + ) 54.1±9.4 58.7±8.6 18.6±15.0 Teff (CD45RA + CCR7 - ) 3.8±1.5 2.6±0.9 2.5±1.6 EM (CD45RA - CCR7 - ) 23.0±6.5 14.4±5.3 51.6±13.4 CM (CD45RA - CCR7 + ) 19.1±4.1 24.3±3.8 27.4±7.6 Treg (CD25 high CD127 - ) 5.0±1.4 5.1±1.9 9.5±3.5 Naïve Treg (CD45RA + CD25 + ) 3.4±2.0 1.9±1.3 1.3±1.2 Differentiated Treg (CD45RA - CD25 ++ ) 3.7±2.1 2.4±1.6 8.4±5.9 Th1 (CCR6 - CXCR3 + CCR4 - ) 4.8±4.0 11.1±2.7 21.3±8.7 Th2 (CCR6 - CXCR3 - CCR4 + ) 8.6±2.7 3.3±1.4 4.9±2.8 Th17 (CCR6 + CXCR3 - CCR4 + ) 5.9±2.8 3.9±1.7 4.8±2.3 Th1-like (CCR6 - CXCR3 + CCR4 - ) 5.3±3.6 6.6±2.9 9.5±4.1 IL-17 + T cells 2.3±1.3 2.6±1.0 4.4±1.3 IFN- γ + T cells 7.5±6.7 7.4±3.3 27.8±15.4 CD8 + T cells 28.6±6.9 30.3±6.3 42.5±5.6 Naive (CD45RA + CCR7 + ) 43.6±11.9 45.3±12.6 15.2±8.0 Teff (CD45RA + CCR7 - ) 26.6±9.1 25.3±11.5 30.4±11.5 EM (CD45RA - CCR7 - ) 23.7±7.0 24.5±13.1 45.8±13.2 CM (CD45RA - CCR7 + ) 6.0±2.2 5.0±1.9 8.7±3.0 NK cells (CD56 + CD3 - ) 8.2±4.8 46.9±16.4 24.3±10.6 CD56 + CD16 - NK cells 11.4±6.7 92.5±5.8 81.6±6.8 CD56 + CD16 + NK cells 88.7±6.7 7.5±5.8 18.5±6.8 MFI CD56 of CD56 + CD16 - NK cells 52.6±15.5 81.2±19.0 18.1±10.8 NKT cells (CD3 + CD56 + ) 1.6±1.1 1.2±0.9 2.5±1.1 B cells (CD19 + ) 6.2±2.5 5.6±2.7 3.6±2.8